Blog

- Uncategorized

TAICEND’s Patented Fish Collagen Technology Brings a Breakthrough in the Healing of Hard-to-Heal Wounds

KAOHSIUNG CITY, Taiwan, Nov. 7, 2025 /PRNewswire/ — TAICEND is set to officially launch its groundbreaking new product — TAICEND Collagen Dressing — in 2026. Extracted from premium fish skin, the collagen is produced through a patented low-temperature extraction technology combined with a proprietary formulation, resulting in a high-purity fish collagen suitable for advanced wound dressings.

Read More »

MedCAD’s AccuStride™ Fixation Plates Receive 510(k) FDA Clearance to Complete Foot and Ankle System Offering

DALLAS, Nov. 6, 2025 /PRNewswire/ — Dallas-based MedCAD has been awarded 510(k) FDA clearance for its AccuStride fixation plates, part of a patient-specific solution available to surgeons as a complete foot and ankle (F&A) system. The company received 510(k) FDA clearance for its foot and ankle guides and planning system in March 2025. The AccuStride implant and surgical guide system coupled with the company’s proprietary planning software will enable foot and ankle surgeons to correct multiple related pathologies in a single procedure.

Read More »

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

CAESAREA, Israel, Nov. 6, 2025 /PRNewswire/ — Nitinotes Ltd., a medical device company transforming the treatment of obesity, today announced it has received CE Mark approval for the EndoZip™ System, the first fully automated suturing platform for endoscopic sleeve gastroplasty (ESG). The milestone clearance enables Nitinotes to begin commercialization across the European Union and other CE Mark-accepting markets.

Read More »